NCT03496103View on ClinicalTrials.gov

Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 12, 2016

Study Completion Date

March 12, 2016

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

ragweed pollen

three hours ragweed pollen in a allergen exposure chamber

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03496103 - Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber | Biotech Hunter | Biotech Hunter